A. Maillet

641 total citations
9 papers, 508 citations indexed

About

A. Maillet is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Maillet has authored 9 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Maillet's work include Pluripotent Stem Cells Research (2 papers), Inhalation and Respiratory Drug Delivery (2 papers) and Chemotherapy-induced cardiotoxicity and mitigation (2 papers). A. Maillet is often cited by papers focused on Pluripotent Stem Cells Research (2 papers), Inhalation and Respiratory Drug Delivery (2 papers) and Chemotherapy-induced cardiotoxicity and mitigation (2 papers). A. Maillet collaborates with scholars based in Singapore, France and Canada. A. Maillet's co-authors include Shazib Pervaiz, Liam R. Brunham, Jolene Ooi, Xiaoran Chai, Sujoy Ghosh, N. Sadananda Singh, Michael R. Hayden, Winston Shim, Mahmoud A. Pouladi and Ashish Mehta and has published in prestigious journals such as Scientific Reports, Antioxidants and Redox Signaling and Pharmaceutical Research.

In The Last Decade

A. Maillet

9 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Maillet Singapore 7 275 116 106 103 54 9 508
Е. Л. Лушникова Russia 10 157 0.6× 70 0.6× 103 1.0× 55 0.5× 49 0.9× 140 475
Miyuki Ito Japan 16 256 0.9× 47 0.4× 51 0.5× 63 0.6× 35 0.6× 43 653
Yihong Kaufmann United States 14 126 0.5× 102 0.9× 74 0.7× 53 0.5× 128 2.4× 29 483
Tanaya R. Vaidya United States 7 158 0.6× 135 1.2× 214 2.0× 60 0.6× 34 0.6× 17 439
Sheila Prachand United States 9 328 1.2× 184 1.6× 101 1.0× 31 0.3× 43 0.8× 20 572
N. Patrick McCabe United States 13 318 1.2× 204 1.8× 24 0.2× 97 0.9× 110 2.0× 17 753
Ningwei Zhao China 15 308 1.1× 51 0.4× 29 0.3× 55 0.5× 73 1.4× 29 565
Takashi Shirakawa Japan 10 153 0.6× 34 0.3× 74 0.7× 35 0.3× 31 0.6× 23 402

Countries citing papers authored by A. Maillet

Since Specialization
Citations

This map shows the geographic impact of A. Maillet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Maillet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Maillet more than expected).

Fields of papers citing papers by A. Maillet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Maillet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Maillet. The network helps show where A. Maillet may publish in the future.

Co-authorship network of co-authors of A. Maillet

This figure shows the co-authorship network connecting the top 25 collaborators of A. Maillet. A scholar is included among the top collaborators of A. Maillet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Maillet. A. Maillet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Huang, Haojun, Sanam Shafaattalab, A. Maillet, et al.. (2020). Variation in RARG increases susceptibility to doxorubicin-induced cardiotoxicity in patient specific induced pluripotent stem cell-derived cardiomyocytes. Scientific Reports. 10(1). 10363–10363. 34 indexed citations
2.
Maillet, A., et al.. (2017). Use of Human Pluripotent Stem Cell Derived‐Cardiomyocytes to Study Drug‐Induced Cardiotoxicity. Current Protocols in Toxicology. 73(1). 22.5.1–22.5.22. 2 indexed citations
3.
Dalloneau, Emilie, Nadine Baroukh, Konstantinos Mavridis, et al.. (2016). Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis. Oncotarget. 7(34). 54415–54429. 37 indexed citations
4.
Maillet, A., Xiaoran Chai, N. Sadananda Singh, et al.. (2016). Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes. Scientific Reports. 6(1). 25333–25333. 131 indexed citations
5.
Maillet, A., et al.. (2013). A novel Osmium-based compound targets the mitochondria and triggers ROS-dependent apoptosis in colon carcinoma. Cell Death and Disease. 4(6). e653–e653. 44 indexed citations
6.
Maillet, A., Laurent Guilleminault, Étienne Lemarié, et al.. (2011). The Airways, a Novel Route for Delivering Monoclonal Antibodies to Treat Lung Tumors. Pharmaceutical Research. 28(9). 2147–2156. 64 indexed citations
7.
Maillet, A. & Shazib Pervaiz. (2011). Redox Regulation of p53, Redox Effectors Regulated by p53: A Subtle Balance. Antioxidants and Redox Signaling. 16(11). 1285–1294. 144 indexed citations
8.
Maillet, A., Nicolas Congy‐Jolivet, Laurent Vecellio, et al.. (2007). Aerodynamical, Immunological and Pharmacological Properties of the Anticancer Antibody Cetuximab Following Nebulization. Pharmaceutical Research. 25(6). 1318–1326. 51 indexed citations
9.
Maillet, A., Nicolas Congy‐Jolivet, J. Hureaux, et al.. (2006). 033 Effet de l’aérosolisation du cetuximab sur la liaison à l’EGFR (Epidermal Growth Factor), son efficacité anti-tumorale in vitro et sa toxicité intrinsèque chez l’animal. Revue des Maladies Respiratoires. 23(5). 528–528. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026